JAMA Medical News
Discussions of timely topics in clinical medicine, biomedical research, public health, health policy, and more, featured in the Medical News section of JAMA, the Journal of the American Medical Association.
What Pennsylvania's Measles Outbreak Signals to the Nation
JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "Is the Pennsylvania Measles Outbreak the New Normal?"
Related Content:
More Women Than Ever Are Using Testosterone
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Testosterone Use Rises Among Women, but Does the Evidence Support It?"
Related Content:
What's Next for Lp(a)?
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Lp(a)-Reducing Agent Pelacarsen Misses the Mark in Phase 3—Now What?"
Related Content:
The Black Market for Investigational GLP-1 Drugs
JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain."
Related Content:
What Happens When Children Use AI for Support?
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss 1 in 5 Children Report Using AI for Emotional Support--Is It Good News or Bad?
Related Content:
Ovarian Cancer Is a Misnomer
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Remove the Fallopian Tubes If the Opportunity Arises, ACOG Says in New Ovarian Cancer Prevention Guidance."
Related Content:
The Challenge of Diagnosing Adult ADHD
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "As More Adults Seek ADHD Care, Primary Care Clinicians Are Tasked With Getting the Diagnosis Right."
Related Content:
Researchers Turn to Viruses to Treat UTIs
JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "Is Phage Therapy the Next Big Hope for Urinary Tract Infections?"
Related Content:
A New Definition of MI and Other Heart Health Highlights From ESC Congress 2026
Hear about a new universal definition of myocardial infarction, updated heart failure guidelines, and other clinical highlights in this interview with Tomasz Guzik, MD, PhD, chair of this year's European Society of Cardiology Congress.
Related Content:
The Fascinating Road to a New Narcolepsy Treatment
The winners of the 2026 Albert Lasker Basic Medical Research Award, Emmanuel Mignot, MD, PhD, and Masashi Yanagisawa, MD, PhD, discuss how they identified the neuropeptide orexin and deduced its role in narcolepsy.
Related Content:
What the Latest Research Says About Preventing Dementia
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Nearly Half of Dementia Cases May Be Preventable—Here's What the Research Says So Far."
Related Content:
Considering Cognition and Frailty in Cardiovascular Care—Too Big an Ask?
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Cardiovascular Care Should Incorporate Cognition and Frailty, Heart Group Says in New Statement."
Related Content:
The Tip of the Iceberg Lettuce
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What the Cyclospora Outbreak Reveals About the State of US Foodborne Disease Surveillance."
Related Content:
FDA Approves the First mRNA Flu Vaccine for the US
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "What to Know About the mRNA Flu Vaccine, Newly Approved by the FDA."
Related Content:
The Slow Evolution of Lyme Disease Care
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Will New Lyme Disease Approaches Change Patient Care?"
Related Content:
Highlights From the 2026 Alzheimer's Association International Conference
Hear the latest on blood-based biomarkers, lifestyle interventions, and more from AAIC 2026 with Gil Rabinovici, MD.
Related Content:
Striking the Balance for Prescribing Opioids
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "A Decade After the CDC's Opioid Prescribing Guidelines, Have Clinicians Struck the Right Balance?"
Related Content:
The Menopause Treatment Boom
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Wild West or Gold Rush: How Long-Neglected Menopause Care Has Spawned a Booming Marketplace."
Related Content:
The First CKM Syndrome Guidelines Are Here
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the First CKM Syndrome Guidelines."
Related Content:
The Testosterone Therapy Debate
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?"
Related Content:
Alzheimer Disease Blood Test May Have Higher Rate of False Positives Than Expected
JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds."
Related Content:
PMOS is the New PCOS
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "PCOS is Now PMOS—Will a New Name Translate to Improved Clinical Care?"
Related Content:
New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions
Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more.
Related Content:
Why Exercise Still Matters in the GLP-1 Drug Era
JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA."
Related Content:
The Search for a Fentanyl Vaccine
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Inside the Push for a Fentanyl Vaccine."
Related Content:
New Insights on HFpEF in Patients With Severe Obesity
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "HFpEF May Be a Different Disease in Patients With Severe Obesity."
Related Content:
Ebola Outbreak Update
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "A Rare Ebola Virus Is Spreading in the DRC—Here's What to Know."
Related Content:
Is There a Doctor on the Ship?
Joining from quarantine, Stephen Kornfeld, MD, discusses his experience stepping in as the ship's physician when hantavirus transformed his vacation cruise into a global public health concern.
Related Content:
Bangladesh's New Measles Crisis
JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "More Than 19 000 Measles Cases in a Month—What the Current Outbreak in Bangladesh Signals to the World."
Related Content:
New Obesity Definition Stirs Debate
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Experts Debate How Obesity Should Be Defined and Diagnosed."
Related Content:
Multi-Cancer Blood Tests Have Arrived
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "These Blood Tests May Detect Dozens of Cancers, but Will They Save Lives?"
Related Content:
Why GLP-1 Drugs Affect Patients Differently
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics."
Related Content:
Treating Methamphetamine Use Disorder With an Antidepressant
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Could a Common Antidepressant Help Treat Methamphetamine Use Disorder?"
Related Content:
Cicada, the SARS-CoV-2 Variant With a Surprising Trajectory
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring."
Related Content:
Cancer-Treating Vaccines Are on the Horizon
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "How mRNA Vaccines Could Help Treat Cancer."
Related Content:
Highlights From the American College of Cardiology's 2026 Scientific Sessions
Hear the latest on PCSK9 inhibitors, cardiorenal benefits of GLP-1 drugs, and other clinical research in this interview with Katie Berlacher, MD, MS, chair of this year's annual ACC meeting.
Related Content:
What Happens When Patients With Decompensated Cirrhosis Stop Drinking?
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "New Hope for Patients With Advanced Alcohol-Related Cirrhosis Who Stop Drinking."
Related Content:
What's New in the Updated Lipid Guidelines?
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the New Lipid Guidelines."
Related Content:
The Health Costs of EPA's Heavy Metal Air Pollution Rollbacks
JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "Why the EPA's Reversal on Heavy Metal Air Pollution Is Cause for Concern."
Related Content:
PrEP Prevents HIV—If Patients Can Get It
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "After a Decade of Progress Against HIV, PrEP Enters a Precarious Era."
Related Content:
